showhide navigation

Chapter Initiatives

HPV Vaccine


hpvtoolkit_logo

Link to and share CDC factsheet and materials with your audiences:

Questions or comments?
Email us at PreteenVaccines@cdc.gov.
Visit us on the web at www.cdc.gov/vaccines/teens


HPV Vaccine Provider Education Video

This video provides up-to-date information about the burden of HPV-related disease, the rationale behind vaccinating pre-teens prior to sexual debut, the clear need for boys as well as girls to receive HPV vaccination, and vaccine safety information. The video features 8 case vignettes in which doctors demonstrate effective counseling strategies, incorporating the latest available evidence, to address the concerns of vaccine-hesitant parents. Thank you to the AAP-CA3 HPV Sub-Committee for sharing this information. Video in full or by segment can be found at: http://www.aapca3.org/hpv-videos-education-promotion/


9-valent Guidance Factsheet

A 9-valent human papillomavirus (HPV) vaccine (Gardasil 9, Merck & Co., Inc) was licensed for use in females and males in the United States in December 2014. 1,2,3,4 9-valent HPV vaccine is the third HPV vaccine licensed by the Food and Drug Administration (FDA); the other vaccines are bivalent HPV vaccine, licensed for use in females, and quadrivalent HPV vaccine, licensed for use in females and males. The information here summarizes some of the recommendations included in the Policy Note and provides additional guidance for issues that were not addressed in the Policy Note but are likely to arise during the transition from quadrivalent HPV vaccine to 9-valent HPV vaccine.

View CDC Information Guide on the 9-Valent Vaccine »


banner

1400526415_BrowserOnline HPV Resources

These HPV resources were compiled by the Pennsylvania Chapter of the American Academy of Pediatrics (paaap.org).

pedialink2PediaLink Course Flyer


Web On-Demand CME Video

Low HPV vaccination rates are leaving another generation of boys and girls vulnerable to devastating HPV cancers. Vaccination could prevent most of these cancers. CDC is looking to you to make a strong recommendation for HPV vaccination when kids are 11 and 12 years old. Provided in this presentation is up-to-date information on HPV infection/disease, HPV vaccine, and ways to successfully communicate with patients and their parents about HPV vaccination. Find out how to tell parents that they aren’t opening the door to sex – they’re closing the door the cancer. Because HPV vaccine IS cancer prevention and YOU are the key.

View CME Video »


CDC Funds DC AAP to Increase the District’s HPV Vaccination Rates

HPV vaccination coverage in the US has stagnated, well below other adolescent vaccines. If pediatricians administered HPV vaccines at the same time they provided other adolescent vaccines, adherence rates would be close to 90%.

Funded by a Center for Disease Control (CDC) grant, through National AAP, the DC AAP chapter is working in collaboration with the DC Department of Health Immunization Program (DCDOH-IP) towards increasing HPV vaccination rates in the District.

To date, DC AAP hosted the DC Pediatric Thought Leaders Immunization Improvement Congress in May, 2014. A group of diverse stakeholders came together to conduct strategic planning and develop an action plan for improving HPV vaccination rates in the District. DC AAP also partnered with the DC Department of Health to send out reminder-recall postcards to over 20,000 families and to offer peer-to-peer presentations to local pediatric practices. The chapter distributed HPV informational posters to DC School Based Health Clinics and hosted a lunch time webinar on giving a strong recommendation for HPV vaccine for a Community Grand Rounds. The webinar remains available on the DC AAP website. Finally, DC AAP distributed member communications regarding HPV vaccination through the chapter’s e-newsletter and social media.

Local Webinar: Improving HPV Vaccination Initiation and Completion in the District of Columbia – with Dr. Sherrie Flynt Wallington, DOH HPV Consultant